PRLD
Prelude Therapeutics Inc
Price:  
3.63 
USD
Volume:  
288,542.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRLD Stock Forecast & Price Target

PRLD Stock Price Forecast

The average stock forecast for Prelude Therapeutics Inc (PRLD) in the next 12 months is 8.67 USD. This price target corresponds to an upside of 137.53%. The range of stock forecasts for PRLD is 6.06 - 10.50 USD. Based on the ratings of 11 analysts, the consensus recommendation for PRLD is BUY.
Target Low Average Median High
Price (USD) 6.06 8.67 9.18 10.50
Upside 66.03% 137.53% 151.51% 187.67%

Recommendation Trends

The latest consensus rating for PRLD is "BUY". This is the average recommendation of 11 analysts: 0 strong sell, 0 sell, 1 hold, 7 buy, 3 strong buy. In the previous period, 9 analysts also majorly recommmended "BUY" for PRLD.

PRLD Financial Stock Forecast

Revenue This Year
44.01M
262.51%
from 12.14M
Revenue Next Year
37.05M
-15.81%
from 44.01M
EPS This Year
-0.42
-66.69%
from -1.25
EPS Next Year
-0.48
15.53%
from -0.42